Search results for "sperm"

showing 10 items of 658 documents

First report of the absence of viral load in testicular sperm samples obtained from men with hepatitis C and HIV after washing and their subsequent u…

2008

Human immunodeficiency virus and hepatitis C infections are sexually transmitted diseases that require sperm samples to be pretreated to eliminate the viral presence before their safe use in assisted reproduction treatments. In this report we describe our experience with sperm washing protocols applied to sperm cells from testicular biopsies as well as the results obtained in subsequent assisted reproduction treatments on seropositive males that are also azoospermic.

AdultMaleendocrine systemSperm RetrievalReproductive Techniques AssistedBiopsySexually Transmitted DiseasesSemenHIV InfectionsHepacivirusTesticleAndrologyTestismedicineHumansSperm Injections IntracytoplasmicAzoospermiaurogenital systembusiness.industrySperm washingObstetrics and GynecologyHIVHepatitis CMiddle AgedViral Loadmedicine.diseaseSpermVirologyHepatitis CSpermatozoamedicine.anatomical_structureReproductive MedicineSperm RetrievalViral diseasebusinessViral loadFertility and sterility
researchProduct

Lower sperm DNA fragmentation after r-FSH administration in functional hypogonadotropic hypogonadism

2013

Abstract PURPOSE: An observational clinical and molecular study was designed to evaluate the effects of the administration of recombinant human FSH on sperm DNA fragmentation in men with a non-classical form of hypogonadotropic hypogonadism and idiopathic oligoasthenoteratozoospermia. METHODS: In the study were included 53 men with a non-classical form of hypogonadotropic hypogonadism and idiopathic oligoasthenoteratozoospermia. In all patients, sperm DNA fragmentation index (DFI), assessed by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate (dUTP) in situ DNA nick end-labelling (TUNEL) assay, was evaluated before starting the treatment with 150 IU of recombinant hum…

AdultMaleendocrine systemmedicine.medical_specialtyDNA FragmentationAsthenozoospermialaw.inventionAndrologyHypogonadotropic hypogonadismlawGamete BiologyInternal medicineGeneticsmedicineHumansApoptosis Gametogenesis DNA SpermSettore BIO/06 - Anatomia Comparata E CitologiaGenetics (clinical)GametogenesisSperm Countbusiness.industryHypogonadismObstetrics and GynecologyOligospermiaGeneral Medicinemedicine.diseaseSpermatozoaSpermRecombinant ProteinsEndocrinologyReproductive MedicineAsthenozoospermiaOligospermiaApoptosisRecombinant DNADNA fragmentationFollicle Stimulating Hormone HumanbusinessDevelopmental Biology
researchProduct

Detection of oncogenic human papillomavirus genotypes on spermatozoa from male partners of infertile couples

2013

Objective To evaluate the prevalence of human papillomavirus (HPV) sperm infection and its correlation with sperm parameters in patients who attended a fertility clinic. Design Cross-sectional clinical study. Setting University-affiliated reproductive medicine clinic. Patient(s) A total of 308 male partners of couples undergoing in vitro fertilization techniques. Intervention(s) Specimens of semen were collected from all patients. Main Outcome Measure(s) Sperm parameters were evaluated according to the World Health Organization manual. The presence of HPV DNA was researched by the combined use of two HPV assays and a highly sensitive nested polymerase chain reaction assay followed by HPV ge…

AdultMaleendocrine systemmedicine.medical_specialtyGenotypeReproductive medicineSemenFertilization in VitroBiologyPolymerase Chain ReactionHuman Papillomavirus DNA TestsMale infertilityAndrologySemen qualityPredictive Value of TestsRisk FactorsGenotypemedicineHumansPapillomaviridaeIn Situ HybridizationInfertility MaleAcademic Medical CentersSperm Counturogenital systemPapillomavirus InfectionsHPV infectionvirus diseasesObstetrics and Gynecologymedicine.diseaseSpermatozoaSpermSettore MED/40 - Ginecologia E Ostetriciafemale genital diseases and pregnancy complicationsFertilityReproductive MedicineCase-Control StudiesDNA ViralSperm MotilitySperm HeadHPV infection semen parameters IVF ICSINested polymerase chain reaction
researchProduct

Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism

1991

Objective The response to subcutaneous (SC) gonadotropin replacement therapy, using human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG) or hCG alone, was evaluated in male hypothalamic hypogonadism. Design Sixteen patients with hypothalamic hypogonadism were treated with gonadotropins for induction of puberty and normalization of spermatogenesis. The results were analyzed retrospectively. Setting The study was carried out in a clinical endocrinology department providing tertiary care and in private practices of endocrinology. Patients Eight patients with idiopathic hypogonadotropic hypogonadism and eight patients with Kallmann's syndrome in prepubertal or early pubert…

AdultMaleendocrine systemmedicine.medical_specialtyMenotropinsAdolescentmedicine.drug_classmedicine.medical_treatmentChorionic GonadotropinInjections IntramuscularHuman chorionic gonadotropinSemen qualityHypogonadotropic hypogonadismInternal medicineTestisHumansMedicineEunuchismTestosteroneSexual MaturationSpermatogenesisRetrospective StudiesChemotherapybiologyurogenital systembusiness.industryHypogonadismObstetrics and Gynecologymedicine.diseaseSpermEndocrinologyReproductive MedicineHMG-CoA reductasebiology.proteinDrug Therapy CombinationGonadotropinbusinessSpermatogenesisFertility and Sterility
researchProduct

Pregnancy in an azoospermic patient with markedly elevated serum follicle-stimulating hormone levels

1995

Objective To assess the possibility of achieving a pregnancy in an azoospermic patient with markedly elevated serum FSH level. Design A case report. Setting In vitro fertilization program at the Instituto Valenciano de Infertilidad. Patient An azoospermic patient with small testes and serum FSH level (38.7 mlU/mL) higher than three times normal. Testicular biopsy revealed Sertoli cell-only syndrome with focal spermatogenesis. Interventions Intracytoplasmic microinjection of testicular tissue-extracted spermatozoa. Main Outcome Measurements: Fertilization rate, cleavage rate, clinical pregnancy. Results Eight of 11 (73%) intact oocytes showed two pronuclei. All of them cleaved normally. Four…

AdultMaleendocrine systemmedicine.medical_specialtyMicroinjectionsmedicine.drug_classmedicine.medical_treatmentFertilization in VitroBiologyIntracytoplasmic sperm injectionAndrologyFollicle-stimulating hormonePregnancyInternal medicineTestismedicineHumansMicroinjectionAzoospermiaPregnancySertoli CellsIn vitro fertilisationurogenital systemObstetrics and GynecologyOligospermiamedicine.diseaseSpermatozoaEndocrinologyReproductive MedicineOocytesFemaleFollicle Stimulating HormoneGonadotropinSpermatogenesisFertility and Sterility
researchProduct

Antral Follicle Priming Before Intracytoplasmic Sperm Injection in Previously Diagnosed Low Responders: A Randomized Controlled Trial (FOLLPRIM).

2015

A low response to controlled ovarian hyperstimulation implies a reduced number of embryos and impaired pregnancy rate. Follicular priming with steroids before controlled ovarian hyperstimulation has been suggested to improve the subsequent ovarian response.The purpose of this study was to determine the best follicular priming protocol in low responders and to investigate the intrafollicular mechanisms triggered by steroid hormone priming.This was a single-center, randomized, parallel, open-label, controlled trial, in two phases.The setting was a university-based in vitro fertilization unit.Potential low responders (n = 99) underwent a first intracytoplasmic sperm injection cycle. Confirmed …

AdultMaleendocrine systemmedicine.medical_specialtyPregnancy RateEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryPriming (immunology)Oocyte RetrievalControlled ovarian hyperstimulationLuteal PhaseAdministration CutaneousBiochemistryIntracytoplasmic sperm injectionlaw.inventionAndrologyEndocrinologyRandomized controlled trialOvarian FollicleOvulation InductionlawPregnancyInternal medicineFollicular phasemedicineHumansTestosteroneSperm Injections IntracytoplasmicOvarian reserveOvarian ReserveIn vitro fertilisationEstradiolbusiness.industryBiochemistry (medical)Antral follicleEndocrinologyFemalebusinessInfertility FemaleThe Journal of clinical endocrinology and metabolism
researchProduct

Testicular sperm from patients with obstructive and nonobstructive azoospermia: aneuploidy risk and reproductive prognosis using testicular sperm fro…

2010

Objective To establish a baseline incidence of chromosomal abnormalities in testicular sperm of fertile men and to determine the best control sample for comparisons with azoospermic males to estimate their reproductive prognosis. Design Prospective study. Setting Infertility clinic. Patient(s) Sixteen obstructive azoospermic (OA) and 19 nonobstructive azoospermic patients (NOA). Control samples were ejaculated sperm from ten fertile donors and testicular sperm from ten other fertile donors. Intervention(s) Fluorescence in situ hybridization (FISH) in sperm. Main Outcome Measure(s) Sperm numerical abnormalities for chromosomes 13, 18, 21, X, and Y; ongoing implantation and pregnancy rates in…

AdultMaleendocrine systemmedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentAneuploidySemenBiologyTesticleIntracytoplasmic sperm injectionAndrologyPregnancyRisk FactorsTestismedicineHumansProspective StudiesSperm Injections Intracytoplasmicreproductive and urinary physiologyIn Situ Hybridization FluorescenceAzoospermiaGynecologyAzoospermiaPregnancymedicine.diagnostic_testurogenital systemIncidenceObstetrics and GynecologyMiddle AgedUniparental Disomymedicine.diseaseAneuploidyPrognosisSpermDiploidySpermatozoamedicine.anatomical_structureFertilityReproductive MedicineFemaleFluorescence in situ hybridizationFertility and sterility
researchProduct

Clinical success of intrauterine insemination cycles is affected by the sperm preparation time.

2013

Objective To determine the impact of the time interval from the end of sperm preparation (TSP) to intrauterine insemination (IUI) on the outcome. Design Prospective multicentre cohort study. Setting Seven French centers (assisted reproduction group in northeastern France, four academic centers, and three clinics). Patient(s) Eight hundred sixty-two IUI cycles (709 patients) managed by gonadotropins were studied. Intervention(s) Cycles were stimulated by either FSH or hMG, and hCG was administrated when the leading follicle diameter measured >15 mm. IUIs were performed ∼36 hours after ovulation triggering. Main Outcome Measure(s) Generalized linear mixed models for binary outcomes were used …

AdultMaleendocrine systemmedicine.medical_specialtyTime FactorsPregnancy Ratemedia_common.quotation_subjectReproductive medicinelaw.inventionSpecimen HandlingSemen qualityRandomized controlled trialOvulation InductionlawPregnancyOdds RatioMedicineHumansProspective StudiesOvulationmedia_commonUnexplained infertilityInsemination Artificial HomologousGynecologyPregnancybusiness.industryAge FactorsObstetrics and GynecologyFertility Agents Femalemedicine.diseaseSpermatozoaTissue DonorsSemen AnalysisPregnancy rateFertilityTreatment OutcomeReproductive MedicineInfertilityMultivariate AnalysisLinear ModelsFemaleFrancebusinessCohort studyFertility and sterility
researchProduct

Fertilization after intracytoplasmic sperm injection with cryopreserved testicular spermatozoa.

1996

Objective To assess the possibility of cryopreserving testicular tissue extracted sperm for intracytoplasmic sperm injection (ICSI). Design A report of two cases. Our study was approved by the Ethical Committee at the Instituto Valenciano de Infertilidad. Setting In vitro fertilization program at the Instituto Valenciano de Infertilidad. Patients Two azoospermic patients with severe spermatogenic failure but with focal spermatogenesis on testicular biopsies. In both cases, a first ICSI attempt with fresh testicular biopsy extracted sperm was unsuccessful. Interventions Cryopreservation of testicular spermatozoa in 100-µL "pills." Intracytoplasmic sperm injection with thawed testicular sperm…

AdultMaleendocrine systemmedicine.medical_specialtyendocrine system diseasesMicroinjectionsmedicine.medical_treatmentBiopsyFertilization in VitroBiologyurologic and male genital diseasesIntracytoplasmic sperm injectionCryopreservationAndrologyTestismedicineHumansreproductive and urinary physiologyAzoospermiaGynecologyCryopreservationIn vitro fertilisationurogenital systemObstetrics and GynecologyOligospermiamedicine.diseaseSpermSpermatozoaTesticular sperm extractionReproductive MedicineFemaleSpermatogenesisEmbryo qualityFertility and sterility
researchProduct

Stimulation of Spermatogenesis and Biological Paternity by Intranasal (Low Dose) Gonadotropin-Releasing Hormone (GnRH) in a Male with Kallmann's Synd…

1987

Intranasal (in) GnRH spray caused induction and maintenance of spermatogenesis and biological paternity in a 28-yr-old man with Kallmann's syndrome. Prior treatment had included GnRH analog administration, which failed to induce puberty, and testosterone (T) enanthate weekly. Prior hCG/human menopausal gonadotropin therapy had resulted in high normal serum T levels and near-normal semen quality, but during subsequent hCG therapy, spermatogenesis markedly decreased. The patient had then received 250 mg T enanthate/month for 2 yr and 7 months; it was discontinued 7 weeks before the in GnRH study began. At its start (July 1984) the subject's testis size was 7 mL, and he had azoospermia, low se…

AdultMaleendocrine systemmedicine.medical_specialtymedicine.drug_classKallmann syndromeEndocrinology Diabetes and MetabolismClinical BiochemistryPaternityGonadotropin-releasing hormoneBiologyBiochemistryOlfaction DisordersEndocrinologyInternal medicinemedicineHumansSpermatogenesisTestosteroneAzoospermiaHypogonadismBiochemistry (medical)Syndromemedicine.diseaseSpermStimulation ChemicalEndocrinologyGonadotropinMenotropinsPituitary Hormone-Releasing HormonesSpermatogenesisGonadotropinshormones hormone substitutes and hormone antagonistsThe Journal of Clinical Endocrinology & Metabolism
researchProduct